SCHEMBL1594957

SCHEMBL1594957

Brc1cccc(/C=N/N=C/c2cccc(Br)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
NPSR1 Q6W5P4 1/20 0.56
CHRM5 P08912 3/20 0.56
NPC1 O15118 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
PKM P14618 1/20 0.56
MAPK1 P28482 1/20 0.56
THPO P40225 1/20 0.56
GRM5 P41594 1/20 0.56
RAB9A P51151 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
POLB P06746 1/20 0.53
PLEC Q15149 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1594961 1.00 ALDH1A1 (0.58) ALDH1A1NPSR1CHRM5NPC1CYP1A2
SCHEMBL20288371 0.82 NPSR1 (0.58) ALDH1A1NPSR1NPC1CYP1A2CYP2D6
SCHEMBL2160781 0.82 ALDH1A1 (0.54) ALDH1A1NPSR1CYP1A2CYP2D6RAB9A
SCHEMBL22925042 0.82 ALDH1A1 (0.54) ALDH1A1NPSR1NPC1CYP1A2CYP2D6
SCHEMBL2160777 0.82 ALDH1A1 (0.54) ALDH1A1NPSR1CYP1A2CYP2D6RAB9A
SCHEMBL5110843 0.82 ALDH1A1 (0.54) ALDH1A1NPSR1CYP1A2CYP2D6RAB9A
SCHEMBL2651780 0.82 ALDH1A1 (0.54) ALDH1A1NPSR1CYP1A2CYP2D6POLB
Hydrochloric Acid SCHEMBL5703066 0.81 FURIN (0.73) NPC1FURIN
SCHEMBL28618284 0.79 ALDH1A1 (0.50) ALDH1A1NPSR1CHRM5CYP1A2CYP2D6
SCHEMBL709614 0.77 HSD17B3 (0.65) ALDH1A1NPSR1CYP2D6PKMMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919504-B2 Thiadiazole modulators of PKB AMGEN INC. (US) 2011-04-05 US disclosed
US-7919504-B2 Thiadiazole modulators of PKB AMGEN INC. (US) 2011-04-05 US disclosed
US-7919504-B2 Thiadiazole modulators of PKB AMGEN INC. (US) 2011-04-05 US disclosed
EP-2167504-A2 THIADIAZOLE MODULATORS OF PKB Amgen, Inc (US) 2010-03-31 EP disclosed
US-20090298836-A1 Thiadiazole modulators of PKB AMGEN INC. (US) 2009-12-03 US disclosed
US-20090298836-A1 Thiadiazole modulators of PKB AMGEN INC. (US) 2009-12-03 US disclosed
US-20090298836-A1 Thiadiazole modulators of PKB AMGEN INC. (US) 2009-12-03 US disclosed
WO-2009011871-A2 THIADIAZOLE MODULATORS OF PKB AMGEN INC. (US) 2009-01-22 WO disclosed
WO-2009011871-A2 THIADIAZOLE MODULATORS OF PKB AMGEN INC. (US) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298836-A1 Thiadiazole modulators of PKB PDK1, PDK2, MTOR ALDH1A1 2642/4885NPSR1 3604/4885CHRM5 4844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.